Cargando…
Next-Generation Sequencing Gene Panels in Inheritable Cardiomyopathies and Channelopathies: Prevalence of Pathogenic Variants and Variants of Unknown Significance in Uncommon Genes
The diffusion of next-generation sequencing (NGS)-based approaches allows for the identification of pathogenic mutations of cardiomyopathies and channelopathies in more than 200 different genes. Since genes considered uncommon for a clinical phenotype are also now included in molecular testing, the...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599286/ https://www.ncbi.nlm.nih.gov/pubmed/36291626 http://dx.doi.org/10.3390/biom12101417 |
_version_ | 1784816557466058752 |
---|---|
author | Mazzaccara, Cristina Lombardi, Raffaella Mirra, Bruno Barretta, Ferdinando Esposito, Maria Valeria Uomo, Fabiana Caiazza, Martina Monda, Emanuele Losi, Maria Angela Limongelli, Giuseppe D’Argenio, Valeria Frisso, Giulia |
author_facet | Mazzaccara, Cristina Lombardi, Raffaella Mirra, Bruno Barretta, Ferdinando Esposito, Maria Valeria Uomo, Fabiana Caiazza, Martina Monda, Emanuele Losi, Maria Angela Limongelli, Giuseppe D’Argenio, Valeria Frisso, Giulia |
author_sort | Mazzaccara, Cristina |
collection | PubMed |
description | The diffusion of next-generation sequencing (NGS)-based approaches allows for the identification of pathogenic mutations of cardiomyopathies and channelopathies in more than 200 different genes. Since genes considered uncommon for a clinical phenotype are also now included in molecular testing, the detection rate of disease-causing variants has increased. Here, we report the prevalence of genetic variants detected by using a NGS custom panel in a cohort of 133 patients with inherited cardiomyopathies (n = 77) or channelopathies (n = 56). We identified 82 variants, of which 50 (61%) were identified in genes without a strong or definitive evidence of disease association according to the NIH-funded Clinical Genome Resource (ClinGen; “uncommon genes”). Among these, 35 (70%) were variants of unknown significance (VUSs), 13 (26%) were pathogenic (P) or likely pathogenic (LP) mutations, and 2 (4%) benign (B) or likely benign (LB) variants according to American College of Medical Genetics (ACMG) classifications. These data reinforce the need for the screening of uncommon genes in order to increase the diagnostic sensitivity of the genetic testing of inherited cardiomyopathies and channelopathies by allowing for the identification of mutations in genes that are not usually explored due to a currently poor association with the clinical phenotype. |
format | Online Article Text |
id | pubmed-9599286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95992862022-10-27 Next-Generation Sequencing Gene Panels in Inheritable Cardiomyopathies and Channelopathies: Prevalence of Pathogenic Variants and Variants of Unknown Significance in Uncommon Genes Mazzaccara, Cristina Lombardi, Raffaella Mirra, Bruno Barretta, Ferdinando Esposito, Maria Valeria Uomo, Fabiana Caiazza, Martina Monda, Emanuele Losi, Maria Angela Limongelli, Giuseppe D’Argenio, Valeria Frisso, Giulia Biomolecules Article The diffusion of next-generation sequencing (NGS)-based approaches allows for the identification of pathogenic mutations of cardiomyopathies and channelopathies in more than 200 different genes. Since genes considered uncommon for a clinical phenotype are also now included in molecular testing, the detection rate of disease-causing variants has increased. Here, we report the prevalence of genetic variants detected by using a NGS custom panel in a cohort of 133 patients with inherited cardiomyopathies (n = 77) or channelopathies (n = 56). We identified 82 variants, of which 50 (61%) were identified in genes without a strong or definitive evidence of disease association according to the NIH-funded Clinical Genome Resource (ClinGen; “uncommon genes”). Among these, 35 (70%) were variants of unknown significance (VUSs), 13 (26%) were pathogenic (P) or likely pathogenic (LP) mutations, and 2 (4%) benign (B) or likely benign (LB) variants according to American College of Medical Genetics (ACMG) classifications. These data reinforce the need for the screening of uncommon genes in order to increase the diagnostic sensitivity of the genetic testing of inherited cardiomyopathies and channelopathies by allowing for the identification of mutations in genes that are not usually explored due to a currently poor association with the clinical phenotype. MDPI 2022-10-03 /pmc/articles/PMC9599286/ /pubmed/36291626 http://dx.doi.org/10.3390/biom12101417 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mazzaccara, Cristina Lombardi, Raffaella Mirra, Bruno Barretta, Ferdinando Esposito, Maria Valeria Uomo, Fabiana Caiazza, Martina Monda, Emanuele Losi, Maria Angela Limongelli, Giuseppe D’Argenio, Valeria Frisso, Giulia Next-Generation Sequencing Gene Panels in Inheritable Cardiomyopathies and Channelopathies: Prevalence of Pathogenic Variants and Variants of Unknown Significance in Uncommon Genes |
title | Next-Generation Sequencing Gene Panels in Inheritable Cardiomyopathies and Channelopathies: Prevalence of Pathogenic Variants and Variants of Unknown Significance in Uncommon Genes |
title_full | Next-Generation Sequencing Gene Panels in Inheritable Cardiomyopathies and Channelopathies: Prevalence of Pathogenic Variants and Variants of Unknown Significance in Uncommon Genes |
title_fullStr | Next-Generation Sequencing Gene Panels in Inheritable Cardiomyopathies and Channelopathies: Prevalence of Pathogenic Variants and Variants of Unknown Significance in Uncommon Genes |
title_full_unstemmed | Next-Generation Sequencing Gene Panels in Inheritable Cardiomyopathies and Channelopathies: Prevalence of Pathogenic Variants and Variants of Unknown Significance in Uncommon Genes |
title_short | Next-Generation Sequencing Gene Panels in Inheritable Cardiomyopathies and Channelopathies: Prevalence of Pathogenic Variants and Variants of Unknown Significance in Uncommon Genes |
title_sort | next-generation sequencing gene panels in inheritable cardiomyopathies and channelopathies: prevalence of pathogenic variants and variants of unknown significance in uncommon genes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599286/ https://www.ncbi.nlm.nih.gov/pubmed/36291626 http://dx.doi.org/10.3390/biom12101417 |
work_keys_str_mv | AT mazzaccaracristina nextgenerationsequencinggenepanelsininheritablecardiomyopathiesandchannelopathiesprevalenceofpathogenicvariantsandvariantsofunknownsignificanceinuncommongenes AT lombardiraffaella nextgenerationsequencinggenepanelsininheritablecardiomyopathiesandchannelopathiesprevalenceofpathogenicvariantsandvariantsofunknownsignificanceinuncommongenes AT mirrabruno nextgenerationsequencinggenepanelsininheritablecardiomyopathiesandchannelopathiesprevalenceofpathogenicvariantsandvariantsofunknownsignificanceinuncommongenes AT barrettaferdinando nextgenerationsequencinggenepanelsininheritablecardiomyopathiesandchannelopathiesprevalenceofpathogenicvariantsandvariantsofunknownsignificanceinuncommongenes AT espositomariavaleria nextgenerationsequencinggenepanelsininheritablecardiomyopathiesandchannelopathiesprevalenceofpathogenicvariantsandvariantsofunknownsignificanceinuncommongenes AT uomofabiana nextgenerationsequencinggenepanelsininheritablecardiomyopathiesandchannelopathiesprevalenceofpathogenicvariantsandvariantsofunknownsignificanceinuncommongenes AT caiazzamartina nextgenerationsequencinggenepanelsininheritablecardiomyopathiesandchannelopathiesprevalenceofpathogenicvariantsandvariantsofunknownsignificanceinuncommongenes AT mondaemanuele nextgenerationsequencinggenepanelsininheritablecardiomyopathiesandchannelopathiesprevalenceofpathogenicvariantsandvariantsofunknownsignificanceinuncommongenes AT losimariaangela nextgenerationsequencinggenepanelsininheritablecardiomyopathiesandchannelopathiesprevalenceofpathogenicvariantsandvariantsofunknownsignificanceinuncommongenes AT limongelligiuseppe nextgenerationsequencinggenepanelsininheritablecardiomyopathiesandchannelopathiesprevalenceofpathogenicvariantsandvariantsofunknownsignificanceinuncommongenes AT dargeniovaleria nextgenerationsequencinggenepanelsininheritablecardiomyopathiesandchannelopathiesprevalenceofpathogenicvariantsandvariantsofunknownsignificanceinuncommongenes AT frissogiulia nextgenerationsequencinggenepanelsininheritablecardiomyopathiesandchannelopathiesprevalenceofpathogenicvariantsandvariantsofunknownsignificanceinuncommongenes |